HIV Treatment in 2025 - How New Treatments and Generics Are Changing the Future of Global Access

HIV Treatment in 2025 - How New Treatments and Generics Are Changing the Future of Global Access

Around the world, people living with HIV are facing two big questions- What’s the best HIV treatment available right now? and How can I afford HIV treatment costs?

Unlike earlier years, in 2025, HIV care has entered a phase that includes -

  • Highly effective single-tablet treatments like Biktarvy® (bictegravir+emtricitabine+tenofovir alafenamide).
  • Long-acting prevention such as lenacapavir (Yeztugo®), dosed only twice a year.

In this blog, we look at these modern HIV medicines and how personal importation offers global access to affordable HIV treatments.

Why Is Biktarvy® the Most Prescribed HIV Medicine Globally?

Biktarvy® is globally preferred because it offers

How Much Does HIV Treatment Cost with Biktarvy®?

While branded Biktarvy® costs around $4,000 in the US and about £880 in the UK for a 30-tablet supply, the Indian generic version from MedsPartner costs less than hundred dollars for the same regimen.

The Role of Generics in Global HIV Control

Generic HIV medications are clinically equivalent to branded versions, but significantly more affordable. When accessed through regulated personal importation services like MedsPartner, they offer several key benefits like significant cost savings that make long-term treatment accessible, with better outcomes.

Impact of Generic HIV Antiretrovirals on UK Patients

Published UK modelling and audit data show that adopting generic antiretroviral drugs could drive massive savings for the NHS—while keeping treatment accessible to more people

  • A cross-sectional analysis of HIV care in England found that switching to generics could reduce the overall budget for treating ~85,000 patients from £10.5 billion to £3.6 billion over 2018–2033, assuming generics cost 10% of branded versions.
  • A pharmacy audit for 2016/17 showed that NHS England saved £10 million by implementing clinically appropriate switches to generic ARVs.

These studies show how generic HIV medicines can make life-saving HIV treatment more affordable and sustainable in the long run.

How Is Personal Importation Changing HIV Access in the UK?

In the UK, personal importation of generic HIV drugs improves access to affordable treatment options. Personal importation laws in the UK permit individuals to order up to a 3-month supply of prescription medicines from abroad for personal use, provided they meet the required safety and documentation standards.

Personal importation is preferred as

  • It gives patients faster access to optimal HIV regimens unvailable through national health services.
  • Significantly reduces out-of-pocket costs by opening pathways to affordable generics for medicines like Biktarvy®.

Due to these advantages, personal importation of HIV medicines can change the global HIV landscape, improving access and reducing the disease burden.

How to Prevent HIV - Gilead’s Twice-Yearly HIV Injection, and Why It’s a Game-Changer

In June 2025, the U.S. FDA approved lenacapavir (Yeztugo®) as the first and only twice-yearly injectable option for HIV prevention (PrEP) in adults and adolescents weighing at least 35 kg.

Why it matters

  • In Phase 3 trials, ≥99.9% of participants receiving Yeztugo® remained HIV-negative, showing near-perfect protection.
  • This regimen requires only two injections per year, making it a far more practical alternative compared to daily oral PrEP.
  • It is a promising option for individuals who struggle with daily pill use due to factors like cost or unstable living conditions.

Gilead has secured royalty-free licensing agreements with six generic manufacturers, including four from India, to supply low-cost lenacapavir in 120 LMICs, alongside plans to provide the drug at no profit until generics are in place. These initiatives support the availability of low-cost Yeztugo® and improve global access through trusted manufacturing hubs like India.

How Does Medspartner Support Safe, Affordable HIV Access and Global Health Equity?

At MedsPartner, we deliver trusted and affordable HIV treatments and life-saving drugs to patients in need, ensuring both safety and efficacy.

What We Offer

  • Genuine HIV treatments, including generics of trusted medicines like Biktarvy® from reputed manufacturers.
  • Legal, fast delivery for personal use in 40+ countries.
  • End-to-end support with prescriptions and all required documentation.
  • Full transparency in sourcing.

Your FAQs About HIV Treatment in 2025 Answered!

Which is the safest and best HIV treatment in 2025?

Biktarvy® remains the preferred med due to its once-daily dosing, minimal side effects, and >95% viral suppression rates, and it is also widely available through generic personal importation, making it affordable.

What is the new HIV injection approved in 2025?

Lenacapavir (Yeztugo®) is the first FDA-approved, twice-yearly injectable for HIV prevention. It offers up to 6 months of protection per dose and is ideal for people who find daily pills hard to maintain. Indian manufacturers are now licensed to produce low-cost generics.

Is it legally allowed to import HIV medicine from India?

Yes, many countries like the UK allow personal importation of up to a 3-month supply of prescription medicine, as long as it’s for personal use, includes a valid prescription, and is sourced from a reliable supplier like MedsPartner.

How much does HIV treatment cost with generic importation?

Generic Biktarvy, for example, costs around £80/month through services like MedsPartner, over 90% lesser than branded options that often cost around £900/month in the UK.

Is generic HIV medicine as effective as the branded version?

Yes. Generics contain the same active ingredients, follow strict manufacturing guidelines, and are clinically proven to provide the same efficacy and safety as branded drugs when sourced from trusted suppliers.


Where to Get Affordable HIV Treatment?

HIV treatment in 2025 has come a long way, offering powerful, life-saving options like Biktarvy® and long-acting therapies. But for many, there is still a barrier of cost and availability. That’s where MedsPartner steps in!

We connect you to trusted, affordable generic HIV medicines through safe, legal personal importation, so cost is no longer a reason to delay care.

Visit medspartner.com or chat with our support team for free guidance on prescriptions, import rules, and shipping to your country.

 

Back to blog